One of the Obama administration’s numerous experiments to reduce the cost of Medicare has provoked fury from cancer doctors.
The administration announced last month it would be trying out a new model to reimburse doctors and providers for the cost of medications administered at outpatient facilities, typically expensive cancer treatments that are delivered intravenously at cancer clinics.
The current system pays doctors the average sales prices of the drug plus 6 percent. The new model will pay doctors the average sales price plus 2.5 percent and a flat fee of $16.80 for every day the medication is used.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
